Abstract
Bacillus anthracis is the gram positive, spore-forming etiological agent of anthrax, an affliction studied because of its importance as a potential bioweapon. Although in vitro transcriptional responses of macrophages to either spore or anthrax toxins have been previously reported, little is known regarding the impact of infection on gene expression in host tissues. We infected Swiss-Webster mice intranasally with 5 LD50 of B. anthracis virulent Ames spores and observed the global transcriptional profiles of various tissues over a 48 hr time period. RNA was extracted from spleen, lung, and heart tissues of infected and control mice and examined by Affymetrix GeneChip analysis. Approximately 580 host genes were significantly over or under expressed among the lung, spleen, and heart tissues at 8 hr and 48 hr time points. Expression of genes encoding for surfactant and major histocompatibility complex (MHC) presentation was diminished during the early phase of infection in lungs. By 48 hr, a significant number of genes were modulated in the heart, including up-regulation of calcium-binding related gene expression, and down-regulation of multiple genes related to cell adhesion, formation of the extracellular matrix, and the cell cytoskeleton. Interestingly, the spleen 8 hr post-infection showed striking increases in the expression of genes that encode hydrolytic enzymes, and these levels remained elevated throughout infection. Further, genes involving antigen presentation and interferon responses were down-regulated in the spleen at 8 hr. In late stages of infection, splenic genes related to the inflammatory response were up-regulated. This study is the first to describe the in vivo global transcriptional response of multiple organs during inhalational anthrax. Although numerous genes related to the host immunological response and certain protection mechanisms were up-regulated in these organs, a vast list of genes important for fully developing and maintaining this response were decreased. Additionally, the lung, spleen, and heart showed differential responses to the infection, further validating the demand for a better understanding of anthrax pathogenesis in order to design therapies against novel targets.
Keywords: Bacillus anthracis, anthrax, Affymetrix microarrays, murine model of infection
1. INTRODUCTION
Bacillus anthracis is a gram-positive, spore-forming bacterium of special interest to the biodefense community. The bacterium possesses two plasmids that are largely responsible for its virulence; the pXO1 plasmid harbors genes that code for anthrax toxins, and the plasmid pXO2 encodes genes for biosynthesis of a unique antiphagocytic capsule [1]. Both pX01 and pXO2 plasmids have been studied to evaluate their potential role during inhalational anthrax using mouse, rabbit, and guinea pig models [2–5]. The plasmid pX01 encodes three components of the protein anthrax toxins: lethal factor, edema factor, and protective antigen. Protective antigen (PA) binds either capillary morphogenesis gene 2 (CMG2) or tumor endothelial marker 8 (TEM8) on the surface of target cells, resulting in a conformational change of PA that enables the binding of either lethal factor (LF) or edema factor (EF) to PA and internalization of the AB-type toxin through a heptameric channel comprised of PA molecules [6]. The capsule, on the other hand, consists of poly-D-glutamic-acid [7], which has a negative net charge that resists phagocytosis by macrophages and dendritic cells [8]. Both toxins have been shown to have adverse effects on their target cells, while the capsule defends against bacterial phagocytosis and the subsequent display of B. anthracis immunopeptidome in a thymus-dependent manner [9].
Following the intentional release of B. anthracis in the United States in 2001 [10], significant anthrax-related research ensued and substantial progress was made regarding the understanding of how this organism elicits disease. Inhaled B. anthracis spores have been shown to reach as deep as the alveoli, where they are rapidly engulfed by alveolar macrophages and dendritic cells sampling the lung microenvironment [11]. A significant portion of the spores germinate into metabolically active, vegetative cells within the host phagocytes and begin multiplying. Transport to the mediastinal lymph nodes soon occurs, whereby the bacteria lyse the macrophage via an unknown mechanism. The organisms are then free to spread through the lymphatic and circulatory systems of the host. As the bacteria disseminate to the bloodstream, the two anthrax toxins (LeTx [LF+PA] and EdTx [EF+PA]) are secreted, causing massive edema and widespread hemorrhage. LeTx and EdTx have each been shown to possess unique strategies to disable the host immune response. LeTx cleaves the N-terminal region of mitogen-activated protein kinase kinases (MAPKKs), resulting in the disruption of a myriad of downstream signaling pathways [12]. This toxin also causes cytolysis of numerous cell types, including human and murine macrophages and endothelial cells [13, 14]. Alternatively, EdTx is an adenylyl cyclase toxin capable of increasing cAMP levels within a vast array of host cell types [15]. More recently, it was reported that EdTx inhibits important functions of various immune cells [16–20]. For instance, EdTx impairs the phagocytic activity of human neutrophils [21], perturbs macrophage cytokine responses [20], and decreases macrophage and T-cell chemotaxis [22].
There is no data to-date, however, regarding the overall transcriptional responses of genes in different organ systems of animals after B. anthracis infection. As a result, it is still unclear how animals and humans succumb to infection [3]. Furthermore, few studies have utilized the Ames strain, a virulent form similar to what was used in the August 2001 attacks in the U.S., for studying B. anthracis and host interactions. Finally, the precise cause of lethality incurred by anthrax has yet to be described. We therefore chose to examine the specific effects of Ames spores on the transcriptional profiles of multiple organs in mice exposed by respiratory challenge to mimic inhalational anthrax.
For our animal model, we chose the Swiss-Webster mouse for several reasons. Outbred strains, such as this one, have advantages over inbred mice due to the heterozygosity of immune alleles [23]. Thus, the high genetic variation of Swiss-Webster mice mirrors that of the diverse human population [24]. Additionally, inbred mice possess many homozygous recessive allelles that may lead to detrimental phenotypes [23]. We utilized nasal instillation, as it is a commonly practiced method of simulating an aerosol challenge, and consequently, the inhalational route of infection. Tissue samples were cultured to detect bacteremia during the course of infection. To analyze the systematic immune effects of anthrax on the host, we utilized a 23-plex cytokine array profiling assay. Finally, in order to assess the effects of infection on mouse major organs, we examined tissue sections of the heart, spleen, and lungs for injury and also employed Affymetrix GeneChips to evaluate global transcriptional regulation of genes in these tissues.
The rationale for our choice of tissues was based on prior observations. The lung was chosen because of its role as the initial focus of infection during inhalational anthrax. Infection of the spleen is significant, because lymphoid homing receptors have been shown to be up-regulated on infected antigen-presenting cells [25]. Studying the transcriptional response of the spleen is also important, because understanding the effect of infection on mixed lymphocytes is essential for the creation of therapeutic regimens, such as effective vaccine strategies. Finally, the paucity of empirical indicators of murine anthrax infection observed in our laboratory and the previously reported negative effects of lethal toxin on hemodynamics in a lethal toxin susceptible rat model [26–28], warranted investigation on the transcriptional response of the heart.
2. RESULTS
2.1. Monitoring B. anthracis levels in the lungs, heart, and spleen during infection
We first evaluated the number of anthrax bacteria within each mouse organ of interest at various times during infection. The animals were infected by the intranasal route with a 5 LD50 dose of Ames spores (5.6 × 104 cfu), and the lungs, heart, and spleen were extracted 8, 24, and 48 hr later. The organs of three animals were pooled at each time point, homogenized, serially diluted, and then plated onto blood agar plates. Results are expressed in Figure 1 as the number of anthrax organisms (cfu) calculated per each whole organ in 3 independent experiments. At 8 hr post-infection, only the lungs contained B. anthracis organisms (approximately 1.8 × 104 cfu). By 24 hr, both the heart and lung had anthrax bacteria (3 × 104 and 1 × 102 cfu, respectively). Forty-eight hours into infection, however, all organs showed dramatic increases in B. anthracis levels. For instance, over 7 × 105 cfu were recovered from the heart, and 1.3 × 106 cfu were detected in the spleen at 48 hr. After confirming the presence of B. anthracis in the organs of interest, we evaluated the pathological consequences of infection in these tissues.
Fig. 1.
B. anthracis infection in murine (n = 3/time point) lungs, heart, and spleen at 8, 24, and 48 hr post-infection. CFU/whole organ.
2.2. Histopathological analysis of B. anthracis-infected tissues
The lungs, heart, and spleen were removed from both uninfected mice and those infected with Ames spores for 48 hr, and processed for H&E and Gram staining. Figure 2 illustrates the presence of B. anthracis in various organs of infected animals. In the lungs, bacilli were present within alveoli, alveolar walls, and small and large vascular lumens. Focally, small areas of perivascular/peribronchiolar edema were observed with numerous bacilli. Hemorrhage was also detected in some alveoli (Panel A). Although occasional bacilli were present within the myocardium, tissue damage to the heart was not observed (Panel B). On the other hand, the spleen displayed large numbers of bacilli accompanied by hemorrhage, congestion, fibrin, and edema. Approximately 75% of the red pulp architecture was effaced due to lymphoid depletion and to a lesser extent, lymphocytolysis. White pulp areas were reduced in size with cell loss, lymphocytolysis, and fibrin deposition mainly at the periphery (Panel C). Overall, these results demonstrated B. anthracis bacilli infiltrating multiple tissue types and eliciting profound pathological consequences in the lungs and spleen.
Fig. 2.
Histopathological analysis of anthrax-infected tissues. Lung (A), heart (B), and spleen (C). Tissues were extracted 48 hr post-infection and stained with H&E. Bar size in the control and infected tissues (20X) = 200 μm while the bar size in the control and infected tissue (40X) was 100 μm.
2.3. B. anthracis infection elicits a biphasic pattern of cytokine secretion in the serum of mice
To further characterize the host response to B. anthracis infection, the systemic cytokine response of infected mice was evaluated. Blood samples were collected at 0, 8, 24, 36, and 48 hr post-infection, and the cytokine levels in sera were measured using a multiplex assay system. Pooled sera from three animals at each time point were assayed in duplicate.
Figure 3 shows that a biphasic response pattern was observed for IL-4, IL-6, G-CSF, KC, RANTES, and MCP-1 in sera of the B. anthracis-infected mice. In these terminally ill animals, anthrax infection induced an initial spike (8 hr), followed by a decline and then a second spike at 48 hr post-infection. IFN-γ showed a biphasic response, though not reaching statistical significance, with a second increase at 36 hr instead of 48 hr as displayed by the other cytokines which showed biphasic response. IL-12 (p40) levels were the highest among the bacteria-induced cytokines at all time points except 36 hr, with levels peaking at 275 pg/ml at 48 hr. TNF-α remained only slightly elevated except for a large increase to 450 pg/ml at 36 hr, making it the cytokine with the greatest concentration at this point. G-CSF showed a significant increase at 8 hr compared to basal levels, while KC significantly increased at 48 hr. No appreciable induction was noticed for IL-2, IL-3, and IL-1β (data not shown).
Fig. 3.

Cytokine array analysis of murine (n = 3/time point) sera at 0, 8, 24, 36, and 48 hr post-infection with Ames spores. Significant changes (p< 0.05) from 0 hr are indicated by asterisk.
2.4. Inhalational anthrax alters the expression of numerous murine genes in the lung, heart, and spleen at both early and late time points
After demonstrating anthrax bacilli infiltration and examining pathological consequences of infection in the lungs, heart, and spleen of infected mice, the host transcriptional response within these organs was investigated. RNA was isolated from the three organs at 8 or 48 hr following intranasal inoculation and subjected to Affymetrix GeneChip analysis. We performed three independent experiments with 3 animals per experiment and per time point. Further, for experiment, tissues from three animals were pooled.
Alterations in gene expression profiles found to be significant were compiled into lists by function and are summarized in Table 1. The complete list of altered genes is provided in the supplemental data (Tables I–VI). Specific examples of altered gene expression at 8 and 48 hr in the lungs, heart, and spleen are shown in Tables 2–7. The lungs and heart showed relatively few changes in gene expression at the early time point of 8 hr (15 and 11 altered genes, respectively), with example genes also listed in Tables 2 and 4. However, 48 hr into the course of infection, the transcriptional response of genes in these two organs increased (Tables 1, 3, and 5). In fact, the heart showed the greatest transcriptional response of genes of all organs at both 8 hr and 48 hr, with 298 genes either up- or down-regulated at the 48 hr time point (a list of selected genes are shown in Table 5). The spleen showed significant alterations in gene expression at both time points of 8 and 48 hr (Table 1), with a selected list of genes shown in Tables 6 and 7. The most notable was a dramatic increase in the expression of genes that code for pancreas-associated enzymes.
Table 1.
summarizing the number of significantly altered genes in each tissue per time point, grouped by function
| Heart 8 hr | Heart 48 hr | Lung 8 hr | Lung 48 hr | Spleen 8 hr | Spleen 48 hr | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Up | Down | Up | Down | Up | Down | Up | Down | Up | Down | Up | Down | |
| Adhesion and Migration | - | - | 5 | 11 | - | - | - | 1 | 3 | - | 4 | 1 |
| Angiogenesis | - | - | - | 2 | - | - | - | - | - | - | - | - |
| Apoptosis | - | - | 3 | - | - | - | - | - | - | 1 | - | - |
| Cytoskeleton Reorganization | - | - | - | - | - | - | - | 2 | - | - | - | - |
| Digestive Enzymes | - | - | - | - | - | - | - | - | 12 | - | 26 | - |
| Electron Transport | - | - | - | - | - | - | - | - | 2 | - | 1 | - |
| Exocytosis | - | - | - | - | - | - | - | - | 1 | - | - | - |
| Growth, Differentiation, and Development | - | 2 | 6 | 24 | - | 2 | - | 4 | 5 | 1 | 3 | 6 |
| Immune and Stress Response | - | - | 10 | 4 | 2 | 2 | 8 | 1 | - | 8 | 10 | 12 |
| Iron Homeostasis | - | 1 | 2 | 1 | - | - | - | - | - | - | - | - |
| Metabolism | 1 | 1 | 16 | 7 | 1 | - | 2 | - | - | - | 4 | 2 |
| Nuclear Structure | - | - | - | - | - | - | - | - | 2 | - | - | - |
| Protein and RNA Processing | 1 | - | 13 | 8 | - | - | 4 | - | 2 | - | 3 | - |
| Signal Transduction | - | - | 11 | 9 | - | - | 2 | - | - | 1 | 2 | - |
| Transcriptional Regulation | - | 1 | 10 | 9 | - | 2 | - | 2 | - | 1 | 6 | 4 |
| Transport | - | - | 8 | 3 | 1 | - | - | 2 | - | - | 2 | 2 |
Table 2.
Genes significantly altered in response to Bacillus anthracis infection in murine lungs at 8 hr
| GenBank ID | Gene Name | Function | FC |
|---|---|---|---|
| Up-regulated in Response to B. anthracis Infection | |||
|
| |||
| AV075715 | Clusterin (Clu) | Stress response | 2.1 |
| NM_138648 | Oxidized low density lipoprotein (lectin-like) receptor 1 (Olr1) | Inflammation; cell adhesion | 1.9 |
|
| |||
| Down-regulated in Response to B. anthracis Infection | |||
|
| |||
| U96752 | Major histocompability complex Q1b (H2-K1) | Antigen presentation | −2.5 |
| BB428671 | Platelet-derived growth factor, D polypeptide (Pdgfd) | Regulation of progression through cell cycle; proliferation | −2.1 |
| AV169310 | Surfactant associated protein C (Sftpc) | Regulation of liquid surface tension; regulatory gas exchange | −2.0 |
FC = fold-change
Negative sign (−) before fold-change value indicates down-regulation
Genes shown more than once were represented by more than one probe set on the array, and each was determined separately to be altered in response to Bacillus anthracis treatment
Table 7.
Genes significantly altered in response to Bacillus anthracis infection in murine spleens at 48 hr
| GenBank ID | Gene Name | Function | FC |
|---|---|---|---|
| Up-regulated in Response to B. anthracis Infection | |||
|
| |||
| Digestive enzymes | |||
| NM_009669 | Amylase 2, pancreatic (Amy2) | Carbohydrate metabolism | 1,042 |
| BI963522 | Chymotrypsin C (caldecrin) (Ctrc) | Proteolysis | 64.1 |
| BI439550 | Elastase 3B, pancreatic (ela3) | Proteolysis | 485.8 |
| AI326372 | Pancreatic lipase (Pnlip) | Lipid catabolism | 287.3 |
| Energy production | |||
| AK007743 | Protein disulfide isomerase associated 2 (Pdia2) | Generation of precursor metabolites and energy | 11.5 |
| Immune response and inflammation | |||
| NM_009883 | CCAATenhancer binding protein (CEBP), beta (Cebpb) | Immune response; inflammation; regulation of macrophage activation/differentiation | 2.6 |
| NM_009841 | CD14 antigen (Cd14) | Inflammation; response to LPS | 2.6 |
| NM_008176 | GRO1 oncogene (Gro1) (Cxcl1) | Immune response; inflammation | 4.5 |
| NM_010555 | Interleukin 1 receptor, type II (Il1r2) | Cell surface receptor linked signal transduction; inflammation | 2.5 |
| NM_011036 | Pancreatitis-associated protein (Pap) | Acute-phase response; inflammation | 16.2 |
| NM_009140 | Small inducible cytokine subfamily, member 2 (Scyb2) (Mip2) | Chemotaxis; inflammation | 4.4 |
| Metabolism | |||
| BB068040 | Glutamic pyruvate transaminase (alanine aminotransferase) 2 (Gpt2) | Metabolism | 2.2 |
| Pancreatic functions | |||
| BC020534 | Cholecystokinin A receptor (Cckar) | Pancreatic growth and enzyme secretion | 6.0 |
| AV050299 | Syncollin (Sycn) | Regulation of exocytosis | 89.0 |
| Protein processing and proteolysis | |||
| NM_025989 | Glycoprotein 2 (zymogen granule membrane) (Gp2) | GPI anchor binding | 25.1 |
| Stress response | |||
| NM_019738 | Nuclear protein 1 (Nupr1) | Cell growth in response to injury and proapoptotic stimuli (putative) | 3.5 |
| Transcription regulation | |||
| AI467599 | cAMP responsive element modulator (Crem) | Regulation of transcription, DNA-dependent | 6.3 |
|
| |||
| Down-regulated in Response to B. anthracis Infection | |||
|
| |||
| Growth and differentiation | |||
| BB770972 | Growth arrest-specific 2 like 3 (Gas2l3) | Cell cycle arrest | −2.3 |
| Immune response and inflammation | |||
| NM_053200 | Carboxylesterase 3 (Ces3) | Acyl-CoA metabolism; response to toxin | −1.9 |
| BE634960 | CD48 antigen (Cd48) | Immune response; T cell activation | −1.7 |
| BC025447 | Immunoglobulin heavy chain (gamma polypeptide) (Igh-6) | Activation of MAPK activity; immunoglobulin mediated immune response | −3.7 |
| M94350 | Immunoglobulin lambda chain (IgL) (Igl-V1) | Humoral immune response | −1.9 |
| BM239828 | Interferon-inducible GTPase (Iigp1) | Cytokine and chemokine mediated signaling pathway | −1.7 |
| NM_011558 | T-cell receptor gamma, variable 4 (Tcrg-V4) | Defense response | −1.6 |
| Metabolism | |||
| AW911807 | Guanine deaminase (Gda) | Hydrolase activity | −3.0 |
| Stress response | |||
| AK004608 | Heat shock 70kD protein 8 (Hspa8) | Regulation of progression through cell cycle; stress response | −2.0 |
| BB442713 | Mitogen-activated protein kinase kinase kinase kinase 5 (Map4k5) | Stress response | −1.5 |
| Transcription regulation | |||
| D45210 | Zinc finger protein (Zfp260) | Regulation of transcription, DNA-dependent | −1.8 |
| Transport | |||
| AI326108 | Intersectin 2 (Itsn2) | Endocytosis; regulation of Rho protein signal transduction | −2.1 |
FC = fold-change
Negative sign (−) before fold-change value indicates down-regulation
Genes shown more than once were represented by more than one probe set on the array, and each was determined separately to be altered in response to Bacillus anthracis treatment
Table 4.
Genes significantly altered in response to Bacillus anthracis infection in murine hearts at 8 hr
| GenBank ID | Gene Name | Function | FC |
|---|---|---|---|
| Up-regulated in Response to B. anthracis Infection | |||
|
| |||
| AB006361 | Prostaglandin D synthetase (Ptgds) | Conversion of PGH2 to PGD2; smooth muscle contraction/relaxation | 1.7 |
|
| |||
| Down-regulated in Response to B. anthracis Infection | |||
|
| |||
| NM_007788 | Casein kinase II, alpha 1 polypeptide (Csnk2a1) | Wnt receptor signaling pathway | −1.8 |
| NM_011638 | Transferrin receptor (Tfrc) | Iron ion homeostasis | −1.9 |
FC = fold-change
Negative sign (−) before fold-change value indicates down-regulation
Genes shown more than once were represented by more than one probe set on the array, and each was determined separately to be altered in response to Bacillus anthracis treatment
Table 3.
Genes significantly altered in response to Bacillus anthracis infection in murine lungs at 48 hr
| GenBank ID | Gene Name | Function | FC |
|---|---|---|---|
| Up-regulated in Response to B. anthracis Infection | |||
|
| |||
| Inflammation and stress response | |||
| NM_020581 | Angiopoietin-like 4 (Angptl4) | Response to hypoxia or starvation; negative regulation of apoptosis; positive regulation of angiogenesis | 3.7 |
| NM_009841 | CD14 antigen (Cd14) | Inflammatory response; Immune response to LPS | 3.5 |
| AA796766 | Metallothionein 2 (Mt2) | Nitric oxide mediated signal transduction | 6.0 |
| NM_011082 | Polymeric immunoglobulin receptor (Pigr) | Secretion of IgA and IgM (apical surface of epithelial cells) | 1.9 |
| Metabolism | |||
| C85932 | Crystallin, lamda 1 (Cryl1) | Fatty acid metabolism | 2.6 |
| Other | |||
| NM_020509 | Resistin like alpha (Retnla) | Hormone signaling | 3.3 |
|
| |||
| Down-regulated in Response to B. anthracis Infection | |||
|
| |||
| Adhesion | |||
| BB477150 | Protein tyrosine phosphatase, receptor type D (Ptprd) | Cell adhesion | −3.2 |
| Cytoskeletal organization | |||
| BM900139 | Actin binding LIM protein family, member 3 (Ablim3) | Cytoskeleton organization and biogenesis | −1.8 |
| Growth and differentiation | |||
| BB428671 | Platelet-derived growth factor, D polypeptide (Pdgfd) | Cell cycle regulation; proliferation | −2.1 |
| NM_016686 | Vascular endothelial zinc finger 1 (Vezf1) | Angiogenesis; endothelial cell development/differentiation; blood vessel morphogenesis | −2.5 |
| Signal transduction | |||
| BB216074 | Protein kinase, cAMP dependent regulatory, type II beta (Prkar2b) | Inhibition of PKA catalytic subunits | −1.7 |
| Stress response | |||
| AB031049 | REV3-like, catalytic subunit of DNA polymerase zeta RAD54 like (Rev3l) | DNA replication; DNA repair; response to DNA damage | −1.6 |
| Transcription regulation | |||
| AI639846 | Transcription factor 4 (Tcf4) | Regulation of transcription, DNA-dependent; development | −1.7 |
FC = fold-change
Negative sign (−) before fold-change value indicates down-regulation
Genes shown more than once were represented by more than one probe set on the array, and each was determined separately to be altered in response to Bacillus anthracis treatment
Table 5.
Genes significantly altered in response to Bacillus anthracis infection in murine hearts at 48 hr
| GenBank ID | Gene Name | Function | FC |
|---|---|---|---|
| Up-regulated in Response to B. anthracis Infection | |||
|
| |||
| Apoptosis | |||
| AV228493 | Interleukin-1 receptor-associated kinase 3 (Irak3) | Cytokine and chemokine mediated signaling pathway; apoptosis | 1.7 |
| NM_010177 | Tumor necrosis factor (ligand) superfamily, member 6 (Tnfsf6); Fas ligand (Fasl) | Apoptosis; immune response | 1.7 |
| Growth, differentiation, and development | |||
| AK004781 | SRY-box containing gene 17 (Sox17) | Regulation of transcription, DNA-dependent; cell differentiation; cardiogenesis | 2.2 |
| Immune response and inflammation | |||
| NM_009921 | Cathelicidin antimicrobial peptide (Camp) | Defense response to bacterium | 1.8 |
| BB030365 | CD8 antigen, alpha chain (Cd8a) | Immune response; cytotoxic T cell differentiation | 1.8 |
| BB530063 | Fc receptor, IgG, low affinity Iib (Fcgr2b) | Negative regulation of type I hypersensitivity;phagocytosis; defense response | 2.1 |
| X03019 | Granulocyte-macrophage colony stimulating factor (GM-CSF) | Immune response; myeloid dendritic cell differentiation | 1.8 |
| NM_008694 | Neutrophilic granule protein (Ngp) | Defense response | 2.3 |
| Iron homeostasis | |||
| BM237750 | Transferrin (Trf) | Iron ion homeostasis | 1.6 |
| Metabolism | |||
| BB503164 | Carbonic anyhydrase 12 (Car12) | One-carbon compound metabolism | 2.4 |
| AV236319 | Carnitine palmitoyltransferase 2 (Cpt2) | Fatty acid metabolism | 2.0 |
| Protein processing | |||
| NM_008456 | Kallikrein 5 (Klk5) | Proteolysis | 2.3 |
| Signal transduction | |||
| AV047570 | Calmodulin 3 (Calm3) | G-protein coupled receptor protein signaling pathway | 3.2 |
| BC019382 | Metallothionein 2A (Mt2a) | Phosphatidylinositol metabolism; Nitric oxide-mediated signaling | 1.9 |
| AV328460 | Tachykinin receptor 3 (Tacr3) | G-protein coupled receptor protein signaling pathway; phosphatidylinositol-calcium second messenger system | 2.0 |
| AV246932 | Regulator of G-protein signaling 2 (Rgs2) | Regulation of G-protein coupled receptor protein signaling pathway | 1.65 |
| Stress response | |||
| BC015260 | FK506 binding protein 5 (51 kDa) (Fkbp5) | Stress response; steroid signaling | 3.2 |
| Transport | 1.7 | ||
| AV323698 | ARP1 actin-related protein 1 homolog A (Actr1a) | Vesicle-mediated transport | 1.9 |
|
| |||
| Down-regulated in Response to B. anthracis Infection | |||
|
| |||
| Adhesion and migration | |||
| NM_009866 | Cadherin 11 (Cdh11) | Cell adhesion | −3.2 |
| BC005676 | Cell surface glycoprotein CD44 (hyaluronate binding protein) (Cd44) | Cell adhesion | −2.3 |
| BF227507 | Procollagen, type I, alpha 2 (Col1a2) | Cell adhesion | −2.3 |
| NM_007737 | Procollagen, type V, alpha 2 (Col5a2) | Cell adhesion | −1.8 |
| NM_011693 | Vascular cell adhesion molecule 1 (Vcam1) | Cell adhesion | −2.7 |
| Angiogenesis | |||
| BB453314 | Angiopoietin 1 (Angtpt1) | Angiogenesis; transmembrane receptor protein tyrosine kinase signaling pathway; development | −2.1 |
| Growth, differentiation, and development | |||
| BC004724 | Fibronectin 1 (Fn1) | Cell morphogenesis; acute-phase response; cell-substrate junction assembly; cell adhesion | −2.2 |
| NM_009627 | Adrenomedullin (Adm) | Heart development; positive regulation of cell proliferation | −1.7 |
| AI323506 | Myelin basic protein (Mbp) | Myelination; cell differentiation | −1.9 |
| C81601 | Tissue inhibitor of metalloproteinase 2 (Timp2) | Negative regulation of cell proliferation;regulation of cAMP metabolism; regulation of MAPKKK signaling | −1.7 |
| Immune response and inflammation | |||
| L23495 | MHC class I H-2K (H2-K1) | Antigen processing and presentation | −2.0 |
| NM_018866 | Small inducible cytokine subfamily B (Cys-X-Cys), member 13 (Scyb13) (Cxcl13) | Chemotaxis; inflammation | −5.4 |
| AY090098 | Interferon, alpha-inducible protein 27 (Ifi27) | Defense response | −3.1 |
| Iron homeostasis | |||
| AK011596 | Transferrin receptor (Tfrc) | Iron ion homeostasis | −1.7 |
| Metabolism | |||
| BB276877 | ATP citrate lyase (Acly) | Acetyl-CoA biosynthesis; lipid metabolism | −3.4 |
| AF127033 | Fatty acid synthase (Fasn) | Fatty acid biosynthesis | −6.7 |
| NM_009127 | Stearoyl-Coenzyme A desaturase 1 (Scd1) | Lipid biosynthesis; superoxide metabolism | −5.2 |
| Protein processing | |||
| AK009847 | Protease, serine, 23 (Prss23) | Proteolysis | −2.5 |
| Signal transduction | |||
| BB746807 | Adenylate cyclase 7 (Adcy7) | cAMP biosynthesis | −2.1 |
| NM_022881 | Regulator of G-protein signaling 18 (Rgs18) | Regulation of G-protein coupled receptor protein signaling pathway | −3.0 |
| Stress response | |||
| BC024835 | Structure specific recognition protein 1 (Ssrp1) | DNA replication; DNA repair | −1.7 |
| Transcription regulation | |||
| BB124537 | Myotrophin (Mtpn) | Regulation of transcription, DNA-dependent | −1.7 |
| Other | |||
| M12481 | Actin, beta, cytoplasmic (Actb) | Structural constituent of cytoskeleton | −1.9 |
| X53753 | Tropomyosin 3, gamma (Tpm3) | Regulation of muscle contraction | −1.7 |
FC = fold-change
Negative sign (−) before fold-change value indicates down-regulation
Genes shown more than once were represented by more than one probe set on the array, and each was determined separately to be altered in response to Bacillus anthracis treatment
Table 6.
Genes significantly altered in response to Bacillus anthracis infection in murine spleens at 8 hr
| GenBank ID | Gene Name | Function | FC |
|---|---|---|---|
| Up-regulated in Response to B. anthracis Infection | |||
|
| |||
| Adhesion and migration | |||
| NM_025989 | Glycoprotein 2 (zymogen granule membrane) (Gp2) | Cell adhesion | 10.7 |
| NM_008411 | Integral membrane-associated protein 1 (Itmap1) | Substrate-bound cell migration, cell attachment to substrate | 4.5 |
| Digestive enzymes | |||
| NM_009669 | Amylase 2, pancreatic (Amy2) | Carbohydrate metabolism | 896.5 |
| NM_007919 | Chymotrypsin C (caldecrin) (Ctrc) | Proteolysis | 95.0 |
| AV076302 | Colipase, pancreatic (Clps) | Lipid catabolism | 586.3 |
| BI439550 | Elastase 3B, pancreatic (Ela3) | Proteolysis | 403.9 |
| AI326372 | Pancreatic lipase (Pnlip) | Lipid catabolism | 186.2 |
| Electron transport | |||
| AK007743 | Protein disulfide isomerase associated 2 (Pdia2) | Electron transport | 8.9 |
| Exocytosis | |||
| AV050299 | Syncollin (Sycn) | Calcium-sensitive regulation of exocytosis in exocrine tissues (putative) | 56.4 |
| Protein processing | |||
| NM_009258 | Serine protease inhibitor, Kazal type 3 (Spink3) | Endopeptidase inhibitor activity | 10.3 |
| Stress response | |||
| AV060866 | Phospholipase A2, group IB, pancreas (Pla2g1b) | Phospholipid metabolism; response to stress; cell proliferation | 26.5 |
| NM_009042 | Regenerating islet-derived 1 (Reg1) | Stress response; association with pancreatic inflammation | 89.3 |
|
| |||
| Down-regulated in Response to B. anthracis Infection | |||
|
| |||
| Apoptosis | |||
| NM_009344 | T-cell death associated gene (Tdag) | Apoptosis; FasL biosynthesis | −1.8 |
| Growth and differentiation | |||
| W77144 | Inhibitor of DNA binding 4 (Id4) | Positive regulation of cell proliferation | −2.2 |
| Immune response | |||
| BE634960 | CD48 antigen (Cd48) | T cell activation (putative) | −1.8 |
| BC018402 | Histocompatibility 2, D region locus 1 (H2-K1) | Antigen presentation | −2.4 |
| BC025447 | Immunoglobulin heavy chain (gamma polypeptide) (Igh-6) | Antigen processing and presentation;immunoglobulin mediated immune response; activation of MAPK activity | −1.8 |
| M74124 | Interferon activated gene 205 (Ifi205) | Immune response | −2.4 |
| NM_011558 | T-cell receptor gamma, variable 4 (Tcrg-V4) | Cellular defense response | −2.4 |
| Signal transduction | |||
| BB229616 | G protein-coupled receptor 171 (Gpr171) | G-protein coupled receptor protein signaling pathway | −2.8 |
| Transcription regulation | |||
| D45210 | Zinc finger protein 260 (Zfp260) | Regulation of transcription, DNA-dependent; development | −1.8 |
FC = fold-change
Negative sign (−) before fold-change value indicates down-regulation
Genes shown more than once were represented by more than one probe set on the array, and each was determined separately to be altered in response to Bacillus anthracis treatment
Although the list of altered genes for the lung at 8 hr post-infection was not large, several genes related to inflammation were up-regulated (i.e., clusterin and oxidized low density lipoprotein; Table 2). Examples of genes that were down-regulated included MHC class I receptor (H2-K1), surfactant associated protein C (Sftpc), and several genes encoding proteins related to cell proliferation. By 48 hr, the lung displayed more dramatic signs of response to infection, including up-regulation of genes involved in hypoxia or inflammation (Table 3). Down-regulated genes included those involved in cell growth, differentiation, and various other cellular processes.
In the heart at 8 hr, the majority of affected genes were down-regulated (Tables 1 and 4). Genes coding for molecules with vastly different functions were affected, such as those involved in nucleotide metabolism (guanine deaminase) and iron homeostasis (transferrin receptor). The receptor for transferrin remained down-regulated by 48 hr, but transferrin itself, as well as ferritin, became slightly up-regulated at this later time point (Table 5). By 48 hr, the heart responded tremendously with regard to transcriptional changes. Many key structural molecules important for cardiac function, including beta actin, collagen, vimentin, and fibronectin, were down-regulated. Expression of multiple genes related to cell adhesion and growth and development were also significantly decreased (i.e., cadherin 11, nuclear protein 1, and cyclin D2; Table 5).
Finally, splenic genes were also very responsive to infection with B. anthracis at both time points (Tables 6 and 7). The most profound effect on the spleen at both 8 and 48 hr post infection was the dramatic increase in expression of genes that coded for pancreatic enzymes such as amylase, elastase 3B, and pancreatic lipase. Interestingly, when serum amylase levels were analyzed (data not shown), no difference was observed in infected versus uninfected mice. Additionally, both time points revealed down-regulation of genes related to the adaptive immune response such as immunoglobulin heavy chains, T-cell receptor gamma (Tcrg-V4), and CD48 antigen (Tables 6 and 7).
2.5. Confirmation of B. anthracis-induced gene expression alterations in mice
In order to confirm the GeneChip findings, real-time RT-PCR was performed on eight genes that were chosen based on their involvement in inflammation, signaling, or physiological processes related to each respective organ (Table 8). RT-PCR experiments were performed in parallel, and fold-change values were determined after normalization of each gene to glyceraldehyde-3-phosphate dehydrogenase (GAPDH). The expression of genes encoding clustrin (Clu), angiopoietin-like 4 (Angpt14), and Retnl (expand; full name of this gene!!) was increased in the lung 2.1-, 3.7-, and 3.3-fold, respectively, as determined by GeneChip analysis. Similarly, RT-PCR of lung tissue samples revealed that these genes were up-regulated 3.98-, 2.81-, and 6.35-fold (Table 8). Two of the pancreatic enzyme-encoding genes that were up-regulated in the spleen by GeneChip analysis, amylase 2 (896.5-fold) and elastase 3b (403.9-fold; Table 6), were also shown to be up-regulated to an even greater extent by the RT-PCR data (3847.6- and 599.2-fold, respectively; Table 8). The transcriptional activities of two genes (Ptgds, Tfrc) from the heart at 8 hr were also in agreement with the RT-PCR data.
Table 8.
Real-time RT-PCR confirmation of altered genes identified by GeneChip analysis
| Gene | Tissue | Time | Affy-metrix Fold Change | RT-PCR Fold Change | Function |
|---|---|---|---|---|---|
| Clusterin | Lung | 8 hr | 2.1 | 3.98 | Molecular chaperone during stress-induced injury. |
| Angiopoietin-like Protein 4 | Lung | 48 hr | 3.67 | 2.8 | Protects vascularity during inflammation; maintains EC matrix. |
| Resistin-like Alpha | Lung | 48 hr | 3.32 | 6.34 | Regulator of apoptosis and glucose uptake in adipose cells. |
| Amylase 2 | Spleen | 8 hr | 896.46 | 3847.6 | Pancreatic enzyme involved in starch metabolism. |
| Elastase 3 | Spleen | 8 hr | 403.86 | 599.19 | Pancreatic enzyme involved in breaking down elastin. |
| T-cell Gamma Variable 4 | Spleen | 8 hr | −2.4 | −1.35 | A variable region on the T-cell receptor. |
| Prostaglandin D2 Synthase | Heart | 8 hr | 1.7 | 2.23 | Involved in muscle contraction and platelet aggregation. |
| Transferrin Receptor | Heart | 8 hr | −1.87 | −1.26 | Receptor involved in iron uptake. |
FC = fold-change
Negative sign (−) before fold-change value indicates down-regulation
Genes shown more than once were represented by more than one probe set on the array, and each was determined separately to be altered in response to Bacillus anthracis treatment
3. DISCUSSION
The hardiness and relative ease of aerosolization [29, 30] of B. anthracis spores, together with their ability to cause significant mortality, [31] resulted in the use of this bacterium as a biological weapon in the United States in 2001. As a result of the intentional release of B. anthracis, five out of the eleven people infected with inhalational anthrax did not survive, despite antibiotic therapy [32]. This event prompted renewed interest in investigating the pathogenesis of this organism with the ultimate goal of developing novel treatments against infection with aerosolized B. anthracis spores.
Past publications have examined the global transcriptional responses of host cells to treatment with the anthrax toxins. For instance, GeneChip analysis of EdTx-treated murine macrophages revealed significant gene alterations that culminated in the modulation of various macrophage functions [20]. Similarly, transcriptional analysis of murine macrophages treated with LeTx [33] or infected with B. anthracis Sterne spores (vaccine strain) has been previously reported [34]. Although these studies exposed abundant macrophage genes seemingly important during interaction with spores or toxins, studies to date have neglected to examine the in vivo host response to B. anthracis spores. Here, we report for the first time, the in vivo global transcriptional responses of genes in the lungs, heart, and spleen of mice intranasally infected with fully virulent B. anthracis Ames spores.
The infectious inoculum chosen for these studies was 5 LD50 (56,000) Ames spores in order to ensure significant disease progression and pathological changes within the examined time frame. Preliminary experiments involved isolating RNA from mice infected 8, 24, 36, 48, and 60 hr post-infection and performing GeneChip analysis as described in the Materials and Methods section. Upon examination of the data, however, the time points showing the most striking gene expression changes occurred at earliest time point examined (8 hr) and at 48 hr post-infection. The transcriptional profiles between the 48 and 60 hr infection time points were very similar; thus, 48 hr was chosen as the final late time point for this study.
The lungs were analyzed because they are the primary route of infection for these experiments and in natural cases of inhalational anthrax. As expected, B. anthracis organisms were recovered from the lungs at all time points tested (8, 24, and 48 hr). Similar to previously reported findings [35–37], the number of organisms significantly increased over time. This supports the proposed model of anthrax infection, whereby spores engulfed by alveolar macrophages travel to the mediastinal lymph nodes, enter the bloodstream, and then disseminate to multiple tissue sites, including the return to the lungs [38, 39]. Histopathological analysis of the lungs at 48 hr post-infection confirmed the presence of bacilli within the alveoli, alveolar walls, and small and large vascular lumens (Figure 2). Focally, small areas of edema and hemorrhage were observed with fibrin. Additionally, some, but not all, infected mice showed mixed cellular infiltrates of neutrophils and mononuclear cells. These findings are consistent with previous microscopic observations in the lungs of mice [40, 41] and non-human primates [40] infected with B. anthracis Sterne spores.
Eight hours subsequent to intranasal inoculation of Ames spores, few transcriptional alterations were detected in the lungs (Table 2). However, the genes that were up-regulated indicated that the lung recognized the onset of an infection. One of the genes that responded with the greatest fold-change encodes clusterin, a molecule known to be elevated following inflammatory stress and localized lung damage [43]. Clusterin protects the lung against apoptotic signals, reactive oxygen species (ROS), and complement factors [44]. Likewise, lectin-like oxidized LDL receptor (Olr1), which was up-regulated 1.9-fold, is associated with inflammatory and endotoxin-induced stress and functions as a vascular tethering ligand for rolling leukocytes [45,46]. Alternatively, several genes involved in the immune response were down-regulated. The gene encoding MHC class I receptor (H2-K1) was down-regulated (2.5-fold) in the lung at 8 hr (Table 2), which may represent a bacterial mechanism of immune evasion by which the bacteria interfere with antigen presentation to host immune effector cells. Notably, the gene encoding surfactant protein C (Sftpc) was down-regulated (2.0-fold) by 8 hr. Sftpc, which normally functions to regulate lung surface tension and gas exchange, has been shown to be decreased in various animal models of inflammation and in response to TNF-α [47]. Sftpc and other surfactant proteins play a role in the innate host defense system of the lung by binding to pattern recognition molecules, such as CD14 [48]. Thus, lower Sftpc levels during anthrax infection may disrupt certain respiratory processes, as well as dampen innate immune defenses.
By 48 hr, the lung showed increased expression of genes related to inflammation, suggesting a more active participation of the immune response against infection (Table 3). This included CD14 antigen (3.5-fold increase), which is a receptor for the lipopolysaccharide (LPS)-binding protein/LPS complex. CD14 is also a cell-activating receptor for peptidoglycan [49], possibly explaining its alteration during infection with B. anthracis. Also, the expressions of the multi-functional metallothionein 2 (Mt2) and polymeric immunoglobulin receptor (pIgR) genes were up-regulated. Besides their ability to bind metal ions, metallothioneins become acute phase proteins during inflammation [50] and possess antioxidant properties that may protect tissues against destructive inflammatory conditions [51, 52]. Further, the Mt2 protein has been shown to be elevated during hyperoxia [53]. pIgR proteins are responsible for mediating the continuous delivery of polymeric immunoglobulins (IgA and IgM) to the mucosal epithelial surface and external secretions. Expression of pIgR is regulated by microbial products through toll-like receptor (TLR) signaling and by host factors, such as cytokines [54]. The elevation of CD14, Mt2, and pIGR gene expression likely assists the lungs in combating the infection and protecting itself from excessive damage resulting from inflammation.
The spleen was the second organ of interest during this study, mainly because it is the largest lymphoid organ in the body and filters the blood. As in other systemic bacterial infections, anthrax bacilli in the bloodstream are trafficked to the spleen and interact with a multitude of mixed lymphocyte populations. B. anthracis organisms did not appear in the spleens of Swiss-Webster mice until 48 hr post-infection. Other published data showed bacteria appearing as early as 20 hr post-inoculation by the intra-tracheal route in Balb/c mice [4, 38]. This discrepancy is perhaps due to differences in the genetic background of the mice, the infection route, or inevitable variations caused by the complicated nature of the mechanism of dissemination employed by B. anthracis. Further, it is possible that organisms were present in the spleen of Swiss-Webster mice at 24 hr, but were not viable. Infected spleens displayed high numbers of bacilli with hemorrhage and edema (Figure 2). Major architectural damage to the red and white pulp regions was also observed. These observations correlated with what has been previously observed by others [37, 41, 55].
The spleen responded with a greater magnitude of transcriptional changes early in infection compared to the lungs and heart, with 86 genes altered at 8 hr post-infection (Table 1). Genes of multiple functional categories, such as cell growth, differentiation, and protein processing, were altered. However, the most striking effects involved those classified as digestive enzymes (Tables 6 and 7), including amylase 2 (896-fold at 8 hr, 1042-fold at 48 hr), elastase 3B (322-fold at 8 hr, 486-fold at 48 hr), and pancreatic lipase (186-fold at 8 hr, 116-fold at 48 hr). The extremely large fold-changes that were observed for these genes, along with very low levels of detectable fluorescence for uninfected splenic samples (data not shown), indicated that these transcripts were not present before infection and were induced in response to B. anthracis. Due to the increase in expression of genes for pancreas-associated enzymes, tissue sections of infected pancreata were examined. Although occasional blood vessels contained low numbers of bacilli, no significant lesions were observed (data not shown). Additionally, plating of pancreatic tissue homogenates also revealed the presence of B. anthracis by 48 hr (data not shown). Previous microarray studies by members of our group involving other bacterial pathogens did not reveal up-regulation of pancreatic digestive enzymes in the spleen of infected animals, suggesting this may be an anthrax-specific response (unpublished data). However, the splenic expression of so-called “pancreatic” enzymes is not a novel observance as amylase 2 and elastase 3b have both been observed in spleen [56] and alternative tissues such as the intestine, liver, and brain [57–59]. The peculiarity of its substantial increase is currently being examined by our laboratory. Another experimental replicate was performed utilizing the portions of spleen distal to the hilum with similar increases in one of the tested enzymes (amylase 2) based on real-time RT-PCR. The number of affected genes in the spleen increased to 124 at 48 hr post-infection (Table 1). The expression of cytokine-related genes, such as Cxcl1, Cxcl2, and IL-1 receptor type II were also increased (Table 7). Similar to findings in the lungs at 48 hr, CD14 expression was increased 2.6-fold. Pancreatitis-associated protein (PaP) is an anti-inflammatory protein that was increased 16.2-fold. PaP expression may be induced during inflammation through several pro- and anti-inflammatory cytokines or by itself. PaP then blocks NF-κβ activation and induces the expression of the anti-inflammatory factor suppressor of cytokine signaling 3 (SOCS3) [60] through the JAK/STAT3 (Janus kinase/Signal Transducers and Activators of Transcription 3)-dependent pathway [61].
Due to the high infectious dose of anthrax spores given, infected animals were close to death by 48 hr post-infection. Therefore, the time-frame was too short for an adaptive immune response to come into play. Even so, there was a noticeable reduction in multiple genes encoding molecules vital for mounting a full adaptive immune response (Table 7). This included immunoglobulin heavy chains and lambda chains, T-cell receptor gamma (Tcrg-V4), and CD48 antigen. T-cell receptor gamma chain is expressed along with the delta chain on the surface of a subset of T lymphocytes. Unlike alpha-beta T-cells, gamma/delta T-cells directly recognize proteins and do not require the antigenic peptides to be presented in complex with the MHC [62]. CD48 has broad immunological roles, including cell adhesion [63] and innate responses to bacterial infection [64], and is required for proper CD4+ T-cell activation [65–67].
The effect of B. anthracis infection on the heart has not been previously addressed, and this was the third organ examined during this study. As a muscular organ with the task of distributing the host’s blood supply, it was speculated that B. anthracis organisms would travel to this major organ at some point during infection. Indeed, samples of heart tissue removed at 24 hr and 48 hr post-infection showed the presence of B. anthracis. Histopathology confirmed the presence of anthrax bacilli in the myocardium; however, no significant lesions or tissue damage were noted in this organ (Figure 2). Although the load of B. anthracis organisms was lower in the heart compared to other tissues tested, this organ exhibited the most remarkable transcriptional response.
Nine of the eleven genes altered in the heart at 8 hr post-infection were down-regulated (Tables 1 and 4). Two notable genes include Csnka1, which is the catalytic α subunit of casein kinase II (CK2), and the receptor for transferrin (Tfrc)[68]. CK2 positively regulates Wingless-type MMTV (mouse mammary tumor virus) integration site family (Wnt) signaling [69, 70], which is associated with tumorigenesis and has also been shown to participate in the inhibition of apoptosis via phosphorylation of the activity-regulated cytoskeletal (ARC) protein [71]. The receptor for transferrin remained down-regulated by 48 hr, but transferrin itself, as well as ferritin, was slightly up-regulated at this later time point. Transferrin is a glycoprotein that binds iron very tightly, but reversibly. Transferrin receptors on the surface of host cells bind transferrin and vesicle acidification releases the iron ions [72]. Most bacterial species require iron for efficient growth and possess specialized systems for iron expropriation. B. anthracis secretes siderophores to scavange iron from the host [73,74]. Altering the expression of genes for transferrin, its receptor, and ferritin may represent a host strategy to prevent the acquisition of iron by B. anthracis.
The heart at 48 hr post-challenge showed the most dramatic change compared to the lungs and spleen in terms of the overall number of altered genes (298 genes; Tables 1 and 5). The receptor for the Fc fragment of IgG (Fcgr2B) was increased 2.1-fold, along with GM-CSF (1.8-fold). Fcgrb is expressed on macrophages, neutrophils, mast cells, and B cells [75]. The alpha chain of the CD8 antigen was increased 1.8 fold. CD8-alpha molecules promote the survival and differentiation of activated lymphocytes into memory CD8 T-cells [76–79]. Additionally, two genes encoding antimicrobial proteins found in specific granules of neutrophils, cathelicidin (Camp) and neutrophilic granule protein (Ngp), were also up-regulated [80]. On the other hand, many genes important for host protection were down-regulated in the heart as a result of anthrax infection. Similar to what was found in the lung at 8 hr, the gene encoding MHC Class I receptor (H2-K1) was also down-regulated in the heart (2-fold).
A trend that appeared in the heart at 48 hr was a decrease in transcription of multiple genes involved in maintaining the underlying structure and cell-cell adhesion of the heart tissue. For instance, three genes involved in collagen formation were down-regulated. Collagens are a family of proteins that form triple-stranded, rope-like structures to strengthen and support many tissues in the body, including cartilage, bone, tendon, and skin. The Col1a1 and Col1a2 genes (both decreased 2.3-fold) produce different components of type I collagen that combine to make a molecule of procollagen, which is then processed to form mature Type I collagen fibrils [81]. Col5a2 (down 1.8-fold) functions in a similar manner to form Type V collagen fibrils [82]. Type V collagen also plays a role in assembling other types of collagen into fibrils in many connective tissues [83–85].
Cadherins, such as Cdh11, are cell surface glycoproteins that mediate Ca2+-dependent cell-cell adhesion [86] and are thought to play an important role in development and maintenance of tissues through selective adhesion activity [87]. The expression of this gene was decreased 3.2-fold (Table 5). CD44, which was decreased 2.3-fold, is involved in many diverse processes such as lymphocyte activation and homing, and adhesion to the extracellular matrix [88]. VCAM-1 is a cell surface glycoprotein expressed by cytokine-activated endothelium that mediates the adhesion of monocytes and lymphocytes during migration. During most inflammatory conditions, VCAM-1 is up-regulated in the endothelium of postcapillary venules [89]. However, this gene was down-regulated 2.7-fold in anthrax-infected hearts.
Of particular interest, there are several genes that by their altered expression could quite possibly hamper cardiac function. For example, adrenomedullin (AM), which was decreased nearly 2-fold (Table 5), is a potent vasodilator peptide that has been shown to protect against cardiovascular damage by prohibiting the induction of oxidative stress [90]. A deficiency in AM, on the contrary, has been shown to increase ROS production resulting in exacerbated oxidative stress and marked tissue damage [91]. The expressions of metabolic genes, namely ATP citrate lyase and fatty acid synthase, were also profoundly decreased at the 48 hr time point in the heart (Table 5). ATP citrate lyase is the primary enzyme responsible for the synthesis of cytosolic acetyl-CoA, which is a crucial component involved in the regulation of carnitine palmitoyltransferase I activity and the rate-determination of mitochondrial fatty acid oxidation in the heart and other tissues [92]. Fatty acid oxidation serves as the principal mode by which energy is produced to maintain adequate heart contraction [93, 94], and any negative shift could thus lead to a reduction in ATP generation within cardiac tissue and subsequently cardiac insuffiency. The decline in fatty acid synthase expression adds to this argument due to its involvement in the biosynthesis of long-chain fatty acids, the substrate used for fatty acid oxidation. Although many of the fatty acids used by the heart come from the circulatory system, a portion is synthesized and stored by the cardiac cells themselves. Lastly, the decline in the expression of tropomyosin 3 (Table 5) suggests possible dysfunction in the contraction of the myocardium, because tropomyosin plays a pivotal role in the actin/myosin machinery responsible for muscle contraction/relaxation.
An interesting pattern was observed in the IL-4, IL-6, G-CSF, KC, RANTES, IFN-γ and MCP-1 levels measured in the sera of anthrax-infected animals. A bimodal response (i.e., an increase at 8 hr, drop at 24 and 36 hr, and spike at 48 hr) was observed (Figure 3). Similarly, this trend was reported for two of these particular cytokines, IL-6 and MCP-1, by Firoved et al. [95] following administration of EdTx to mice. Excluding IL-4, the affected cytokines are pro-inflammatory and mediate recruitment of various immune cells such as neutrophils, basophils, T-cells, and monocytes. The spike at 8 hr may be indicative of the immediate immune response to inhalation of a foreign pathogen. For instance, murine cells are capable of recognizing dormant spores via the MyD88 receptor, and they respond with production of inflammatory cytokines [96].
Additionally, because alveolar macrophages rapidly engulf spores, by 8 hr these phagocytic cells are likely contributing with their own cytokine secretion. However, at later time points of 24 and 36 hr, large amounts of LeTx and EdTx are likely released into the bloodstream. Each of these toxins has unique immunomodulatory properties, including cytokine abrogation. In both the mouse model and tissue culture systems, EdTx results in increased IL-6 secretion concomitant with impairment of the TNF-α response [95, 97]. In vitro, LeTx decreases IFN-γ, IL-2, and IL-4 production in rats [25]. Additionally, LeTx has been shown to suppress the production of TNF-α and IL-1β in murine macrophage cell lines [98]. Thus, the combined action of these two toxins may contribute to the observed drop in cytokine levels at 24 and 36 hr post-infection.
By 48 hr following inoculation with Ames spores, the mice were terminally ill. High titers of B. anthracis bacilli plagued the bloodstream and infiltrated multiple tissues as confirmed with histopathology. The second jump in certain cytokine levels (Figure 3) may result from host cells recognizing pattern-associated molecular products being shed by the bacteria, such as anthrolysin O [99] and peptidoglycan [100]. Perhaps this was the last attempt by the immune system to call in professional immune cells to try and control the infection. Analysis of the levels of selected biochemical components in the blood of infected mice was also performed. Although levels of three hepatic transaminases (alkaline phosphate, alanine aminotransferase, and aspartate aminotransferase) increased (2–3 fold) at 48 hr compared to normal mice, which is often indicative of liver injury or dysfunction [101, 102], the increases were not statistically significant (data not shown). No significant changes were observed for the remaining parameters.
In summary, the use of virulent B. anthracis Ames spores and an intranasal infection route in mice allowed us to closely mimic conditions resembling the intentional release of weaponized, aerosolized anthrax spores. Stringent GeneChip analysis data revealed that the lungs, heart, and spleen of the infected mice underwent drastic transcriptional changes during early and late stages of the disease. Although numerous genes related to the host immunological response and various protection mechanisms were up-regulated in these organs, vast numbers of genes important for fully developing and maintaining this response were decreased. By identifying genes that play major roles during anthrax disease progression, we have attempted to provide investigators in the anthrax and biodefense fields with new information about transcriptional gene profiling during infection to advance the effort toward creating novel therapeutic strategies against this deadly disease.
4. MATERIALS AND METHODS
4.1. Mouse nasal inoculation
Specific pathogen-free (SPF) female Swiss Webster 7–8 week old mice were purchased from Taconic Farms (Georgetown, NY) and housed in the Association for Assessment and Accreditation of Laboratory Animal Care-accredited Animal Resources Center at UTMB. Mice were anesthetized with an intraperitoneal (i.p.) injection of ketamine-HCl (90 mg/kg) and xylazine-HCl (10 mg/kg). After anesthesia, the mice were suspended by their front incisors to facilitate nasal inoculation. Mice were given 5 LD50 (approximately 5.6 × 104 colony forming units [cfu]) of B. anthracis Ames strain spores in 40 μl of phosphate buffered saline (PBS), after which the mice remained suspended for an additional 1–2 min to ensure a complete lung inoculation. Subsequently, the mice were returned to their cages for the appropriate incubation time. All animal experiments were performed in accordance with the regulations of the UTMB Institutional Animal Care and Use Committee and the NIH Office of Laboratory Animal Welfare.
4.2. Determining B. anthracis levels in mouse organs
At 8, 24, and 48 hr post-infection, infected mice were anesthetized, followed by euthanasia by CO2 narcosis. Cervical dislocation was subsequently performed to ensure death. Lungs, hearts, and spleens were aseptically removed from 3 mice and placed in 1 ml of PBS in 50-ml Kendall tissue homogenizers (Kendell, Mansfield, MA). Following homogenization of the tissues in the biological safety cabinet in our approved biological safety level (BSL)-2 or animal BSL-3 laboratories, serial dilutions of the samples were made in PBS and 100 μl of each dilution was plated on 5% sheep blood agar plates (BD Biosciences, Franklin Lakes, NJ); which were incubated overnight at 37°C. In total, 3 independent experiments representing 3 biological replicates each were performed, and data were statistically analyzed using one-way ANOVA.
4.3. Tissue fixation and slide preparation
At 48 hr post-infection, aseptic collection of organs was performed as described above. The tissues were fixed in 4% paraformaldehyde for 48 hr and tested for viable bacteria by plating on blood agar plates. Tissue sections were routinely processed, embedded in paraffin, mounted on slides, and stained with hematoxylin and eosin (H&E), as well as the gram stain at the University of Texas, M.D. Anderson Cancer Center. Bacterial load and tissue architecture was evaluated and compared to that of control mice that were given only PBS.
4.4. Cytokine profiling
Infected mice were sacrificed at 8, 24, 36, or 48 hr post infection. A 22-gauge needle was used to perform a cardiac puncture and approximately 1 ml of blood was removed and placed in Microtainer serum separator tubes (BD Biosciences) at 4°C overnight. Blood was centrifuged at 1,000 × g for 10 min and the serum transferred to a new tube, filtered with a 0.22 μm syringe filter, plated overnight to ensure sterility, and stored at −20°C until assayed. The sera of three mice from the control, 8, 24, 36, and 48 hr experimental groups were analyzed using a 23-plex Bioplex kit (Bio-RAD, Herculus, CA). Three replicates were performed and statistically parsed by one-way ANOVA. Whole blood from the aforementioned groups was used in conjunction with the ProChem V analyzer and a panel of biochemistry cuvettes (Drew Scientific Inc., Dallas, TX) to assess biochemical profiles. Analysis was performed as recommended by the manufacturer to measure the serum levels of amylase, alkaline phosphatase (AKP), alanine aminotransferase (ALT), aspartate aminotransferase (AST), bicarbonate, calcium, and glucose.
4.5. Affymetrix GeneChip analysis
Hearts, spleens, and lungs were aseptically removed from three anesthetized mice at 8 and 48 hr post-infection and placed in 50-ml tissue homogenizers with 1 ml RNALater (Ambion, Austin Inc., TX) on ice and immediately transferred to −80°C for storage. Due to the proximity of the pancreatic tail to the hilum of the spleen, great care was taken in isolating only the spleen during tissue extraction. The RNAqueous kit (Ambion) was used to purify RNA from the tissue homogenates. The RNA was allowed to precipitate overnight and then resuspended in a volume of 20 μl diethylpyrocarbonate-treated water. Pellets were stored at −80°C. Subsequently, RNA samples were tested for sterility by streaking on 5% sheep blood agar plates. An Agilent chip was then used to analyze the purity of RNA samples, and the corresponding cDNA was applied to Affymetrix murine GeneChips (430 Plus 2; Affymetrix, Santa Clara, CA) for transcriptional profiling of genes in different organs.
Briefly, total RNA (25 μg) was processed and hybridized to GeneChip arrays in the Molecular Genomics Core at UTMB. The cDNA synthesis, in vitro transcription, and labeling and fragmentation to produce the oligonucleotide probes were performed as instructed by the GeneChip manufacturer (Affymetrix). The probes were first hybridized to a test array (Affymetrix) and then to the 430 Plus 2 GeneChip, both performed using the GeneChip Hybridization Oven 640. The chips were washed in a GeneChip Fluidics Station 400 (Affymetrix) and the results visualized with a Gene Array scanner using the Affymetrix software. These experiments were performed in triplicate, and the data were analyzed separately using three different softwares: GeneSifter (VizX Labs, Seattle, WA), Significance Analysis of Microarrays (SAM; Stanford, CA) and Spotfire DecisionSite 9.0 (Spotfire Inc., Somerville MA). Changes in gene expression were considered significantly altered if the p value was less than 0.05, the fold-change value was at least 1.5, and alteration in gene expression occurred in all 3 experiments. Additionally, genes that were altered between any two uninfected control samples were disregarded, as these alterations most likely represented normal variations among mice. The data discussed in this publication will be deposited in NCBIs Gene Expression Omnibus (GEO, http://www.ncbi.nlm.nih.gov/geo/) and will be accessible through GEO series accession number prior to the publication of this manuscript.
4.6. Real-time reverse transcriptase-polymerase chain reaction (RT-PCR)
Real-time quantitative RT-PCR was performed in the Prism 7000 Sequence Detection System (Applied Biosystems, Foster City, CA) using SYBR Green PCR Master Mix (Applied Biosystems). RNA samples were first quantified using a Nanodrop Spectrophotometer (Nanodrop Technologies Inc., Wilmington, DE) and qualified by analysis on an RNA Nano chip using the Agilent 2100 Bioanalyzer (Agilent Technologies Inc, Santa Clara, CA). Synthesis of cDNA was performed using 1 μg of RNA in a 20-μL-reaction volume containing reagents from the Taqman Reverse Transcription Reagents kit (Applied Biosystems). Q-PCR amplifications were performed in triplicate, using 2 μl of cDNA in a total volume of 25 μl containing SYBR Green and 900 nM primers. Custom-designed primers used for real-time PCR amplification are listed in Table 9.
Table 9.
Custom-designed primers used for confirmation of gene alterations induced by anthrax infection.
| Genes encoding proteins | Forward Primer (5′–3′) | Reverse Primer ( 5′–3′) |
|---|---|---|
| Tfrc | AGAGACAGCAATTGGATTAGCAAA | ATCCTCACAAAAACAAAAAGAAACTG |
| Angpt14 | CCCCCAATGGCCTTTCC | AAACCACCAGCCACCAGAGA |
| Clu | ATGAAGTTCTATGCACGTGTCTGC | GTCGCCGTTCATCCAGAAGT |
| Ela3 | GGCCACTGCATCTCGACTTC | ATCACCTGTTCTTGGCCTTCCT |
| Ptgds | TGCAGCCCAACTTTCAACAA | TTGCACATATACAATACAGCTTTCTTCTC |
| Retnla | TCCAGCTAACTATCCCTCCACTGTA | AGTCATCCCAGCAGGGCAG |
| Tcrg-V4 | GGGAAGCCAACCTGGCA | AATTGATATTTCAGGTTGCTCCAAC |
| Amy2 | GGACTTTAACGATAATAAATGTAATGGAGAA | CAAGTGCAAGATCCAGAAGGC |
A typical protocol included reverse transcription at 50°C for 2 min and a denaturation step at 95°C for 10 min followed by 40 cycles with 95°C denaturation for 15 s and 60°C annealing/extension step for 1 min. To confirm amplification specificity, the PCR products were subjected to a melting curve analysis. Negative controls containing water instead of RNA were concomitantly assayed to confirm that the samples were not cross-contaminated. Targets were normalized to reactions performed using 18S rRNA amplimers, and fold change was determined using the comparative threshold method [103].
Supplementary Material
Acknowledgments
This research was supported by the U.S. Army Grant (DAMD 170210699), the NIH (U01 AI 5385802 and N01 AI 30065), and NIH/NIAID Western Regional Center of Excellence 1U54 AI057156-01. Cristi L. Galindo received support from an NIH cardiology fellowship, Cardiology Department, University of Texas Southwestern Medical Center. We would like to thank Dr. T. Wood and his staff from the department of Biochemistry and Molecular Biology at UTMB for providing facility of his core laboratory for microarray studies.
Footnotes
Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.
References
- 1.Luna VA, et al. Bacillus anthracis virulent plasmid pX02 genes found in large plasmids of two other Bacillus species. J Clin Microbiol. 2006;44:2367–77. doi: 10.1128/JCM.00154-06. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Drysdale M, et al. Capsule synthesis by Bacillus anthracis is required for dissemination in murine inhalation anthrax. Embo J. 2005;24:221–7. doi: 10.1038/sj.emboj.7600495. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Mock M, Mignot T. Anthrax toxins and the host: a story of intimacy. Cell Microbiol. 2003;5:15–23. doi: 10.1046/j.1462-5822.2003.00253.x. [DOI] [PubMed] [Google Scholar]
- 4.Heninger S, et al. Toxin-deficient mutants of Bacillus anthracis are lethal in a murine model for pulmonary anthrax. Infect Immun. 2003;74:6067–74. doi: 10.1128/IAI.00719-06. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Coker PR, et al. Bacillus anthracis virulence in Guinea pigs vaccinated with anthrax vaccine adsorbed is linked to plasmid quantities and clonality. J Clin Microbiol. 2003;41:1212–8. doi: 10.1128/JCM.41.3.1212-1218.2003. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Mourez M. Anthrax toxins. Rev Physiol Biochem Pharmacol. 2004;152:135–64. doi: 10.1007/s10254-004-0028-2. [DOI] [PubMed] [Google Scholar]
- 7.Joyce J, et al. Immunogenicity and protective efficacy of Bacillus anthracis poly-gamma-D-glutamic acid capsule covalently coupled to a protein carrier using a novel triazine-based conjugation strategy. J Biol Chem. 2006;281:4831–43. doi: 10.1074/jbc.M509432200. [DOI] [PubMed] [Google Scholar]
- 8.Ezzell JW, Welkos SL. The capsule of Bacillus anthracis, a review. J Appl Microbiol. 1999;87:250. doi: 10.1046/j.1365-2672.1999.00881.x. [DOI] [PubMed] [Google Scholar]
- 9.Wang TT, Lucas AH. The capsule of Bacillus anthracis behaves as a thymus-independent type 2 antigen. Infect Immun. 2004;72:5460–3. doi: 10.1128/IAI.72.9.5460-5463.2004. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Kiratisin P, et al. Large-scale screening of nasal swabs for Bacillus anthracis: descriptive summary and discussion of the National Institutes of Health’s experience. J Clin Microbiol. 2004;40:3012–6. doi: 10.1128/JCM.40.8.3012-3016.2002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Cleret A, et al. Lung Dendritic Cells Rapidly Mediate Anthrax Spore Entry through the Pulmonary Route. J Immunol. 2007;178:7994–8001. doi: 10.4049/jimmunol.178.12.7994. [DOI] [PubMed] [Google Scholar]
- 12.Chakrabarty K, et al. Human Lung Innate Immune Response to Bacillus anthracis Spore Infection. Infect Immun. 2007;75:3729–38. doi: 10.1128/IAI.00046-07. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Muehlbauer SM, et al. Anthrax lethal toxin kills macrophages in a strain-specific manner by apoptosis or caspase-1-mediated necrosis. Cell Cycle. 2007;6:758–66. doi: 10.4161/cc.6.6.3991. [DOI] [PubMed] [Google Scholar]
- 14.Kirby JE. Anthrax lethal toxin induces human endothelial cell apoptosis. Infect Immun. 2007;72:430–9. doi: 10.1128/IAI.72.1.430-439.2004. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Leppla SH. Anthrax toxin edema factor: a bacterial adenylate cyclase that increases cyclic AMP concentrations of eukaryotic cells. Proc Natl Acad Sci U S A. 1982;79:3162–6. doi: 10.1073/pnas.79.10.3162. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Paccani SR, et al. Anthrax toxins suppress T lymphocyte activation by disrupting antigen receptor signaling. J Exp Med. 2005;201:325–31. doi: 10.1084/jem.20041557. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Comer JE, et al. Direct inhibition of T-lymphocyte activation by anthrax toxins in vivo. Infect Immun. 2005;73:8275–81. doi: 10.1128/IAI.73.12.8275-8281.2005. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Cleret A, et al. Resident CD11c+ lung cells are impaired by anthrax toxins after spore infection. J Infect Dis. 2005;194:86–94. doi: 10.1086/504686. [DOI] [PubMed] [Google Scholar]
- 19.Crawford MA, et al. Bacillus anthracis toxins inhibit human neutrophil NADPH oxidase activity. J Immunol. 2006;176:7557–65. doi: 10.4049/jimmunol.176.12.7557. [DOI] [PubMed] [Google Scholar]
- 20.Comer JE, et al. Murine macrophage transcriptional and functional responses to Bacillus anthracis edema toxin. Microb Pathog. 2006;41:96–110. doi: 10.1016/j.micpath.2006.05.001. [DOI] [PubMed] [Google Scholar]
- 21.O’Brien J, et al. Effects of anthrax toxin components on human neutrophils. Infect Immun. 1985;47:306–10. doi: 10.1128/iai.47.1.306-310.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Rossi Paccani S, et al. Anthrax toxins inhibit immune cell chemotaxis by perturbing chemokine receptor signalling. Cell Microbiol. 2007;9:924–9. doi: 10.1111/j.1462-5822.2006.00840.x. [DOI] [PubMed] [Google Scholar]
- 23.Toapanta F, Ross T. Mouse strain-dependent differences in enhancement of immune responses byC3d. Vaccine. 22:1773–81. doi: 10.1016/j.vaccine.2003.10.050. [DOI] [PubMed] [Google Scholar]
- 24.Im E, Hanke T. Preclinical evaluation of candidate HIV Type 1 vaccines in inbred strains and outbred stock of mice. AIDS Res and human retroviruses. 23:857–862. doi: 10.1089/aid.2007.0009. [DOI] [PubMed] [Google Scholar]
- 25.Brittingham KC, et al. Dendritic cells endocytose Bacillus anthracis spores: implications for anthrax pathogenesis. J Immunol. 2005;174:5545–52. doi: 10.4049/jimmunol.174.9.5545. [DOI] [PubMed] [Google Scholar]
- 26.Cui X, et al. Bacillus anthracis edema and lethal toxin have different hemodynamic effects but function together to worsen shock and outcome in a rat model. J Infect Dis. 2007;195:572–80. doi: 10.1086/510856. [DOI] [PubMed] [Google Scholar]
- 27.Cui X, et al. Sublethal doses of Bacillus anthracis lethal toxin inhibit inflammation with lipopolysaccharide and Escherichia coli challenge but have opposite effects on survival. J Infect Dis. 2006;193:829–40. doi: 10.1086/500468. [DOI] [PubMed] [Google Scholar]
- 28.Cui X, et al. Lethality during continuous anthrax lethal toxin infusion is associated with circulatory shock but not inflammatory cytokine or nitric oxide release in rats. Am J Physiol Regul Integr Comp Physiol. 2004;286:699–709. doi: 10.1152/ajpregu.00593.2003. [DOI] [PubMed] [Google Scholar]
- 29.Jernigan JA, et al. Bioterrorism-related inhalational anthrax: the first 10 cases reported in the United States. Emerg Infect Dis. 2001;7:933–44. doi: 10.3201/eid0706.010604. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Weis CP, et al. Secondary aerosolization of viable Bacillus anthracis spores in a contaminated US Senate Office. Jama. 2002;288:2853–8. doi: 10.1001/jama.288.22.2853. [DOI] [PubMed] [Google Scholar]
- 31.Sanderson WT, et al. Bacillus anthracis contamination and inhalational anthrax in a mail processing and distribution center. J Appl Microbiol. 2004;96:1048–56. doi: 10.1111/j.1365-2672.2004.02223.x. [DOI] [PubMed] [Google Scholar]
- 32.Whitby M, et al. Biological agents as weapons 2: anthrax and plague. Med J Aust. 2002;176:605–8. doi: 10.5694/j.1326-5377.2002.tb04594.x. [DOI] [PubMed] [Google Scholar]
- 33.Inglesby TV, et al. Anthrax as a biological weapon, 2002: updated recommendations for management. Jama. 2002;287:2236–52. doi: 10.1001/jama.287.17.2236. [DOI] [PubMed] [Google Scholar]
- 34.Comer JE, et al. GeneChip analyses of global transcriptional responses of murine macrophages to the lethal toxin of Bacillus anthracis. Infect Immun. 2005;73:1879–85. doi: 10.1128/IAI.73.3.1879-1885.2005. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Bergman NH, et al. Murine macrophage transcriptional responses to Bacillus anthracis infection and intoxication. Infect Immun. 2005;73:1069–80. doi: 10.1128/IAI.73.2.1069-1080.2005. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Berdjis CC, et al. Pathogenesis of respiratory anthrax in Macaca mulatta. Br J Exp Pathol. 1962;43:515–24. [PMC free article] [PubMed] [Google Scholar]
- 37.Kobiler D, et al. Protective antigen as a correlative marker for anthrax in animal models. Infect Immun. 2006;74:5871–6. doi: 10.1128/IAI.00792-06. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Lyons CR, et al. Murine model of pulmonary anthrax: kinetics of dissemination, histopathology, and mouse strain susceptibility. Infect Immun. 2004;72:4801–9. doi: 10.1128/IAI.72.8.4801-4809.2004. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Lincoln RE, et al. Role of the lymphatics in the pathogenesis of anthrax. J Infect Dis. 1965;115:481–94. doi: 10.1093/infdis/115.5.481. [DOI] [PubMed] [Google Scholar]
- 40.Friedlander AM, et al. Postexposure prophylaxis against experimental inhalation anthrax. J Infect Dis. 1993;167:1239–43. doi: 10.1093/infdis/167.5.1239. [DOI] [PubMed] [Google Scholar]
- 41.Duong SL, et al. Histopathology in a murine model of anthrax. Int J Exp Pathol. 2006;87:131–7. doi: 10.1111/j.0959-9673.2006.00473.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Stearns-Kurosawa DJ, et al. Sepsis and pathophysiology of anthrax in a nonhuman primate model. Am J Pathol. 2006;169:433–44. doi: 10.2353/ajpath.2006.051330. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.Carnevali S, et al. Clusterin decreases oxidative stress in lung fibroblasts exposed to cigarette smoke. Am J Respir Crit Care Med. 2006;174:393–9. doi: 10.1164/rccm.200512-1835OC. [DOI] [PubMed] [Google Scholar]
- 44.Heller AR, et al. Clusterin protects the lung from leukocyte-induced injury. Shock. 2003;20:166–70. doi: 10.1097/01.shk.0000075569.93053.b3. [DOI] [PubMed] [Google Scholar]
- 45.Honjo M, et al. Lectin-like oxidized LDL receptor-1 is a cell-adhesion molecule involved in endotoxin-induced inflammation. Proc Natl Acad Sci U S A. 2003;100:1274–9. doi: 10.1073/pnas.0337528100. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46.Hamilton TA, et al. The effects of oxidized low density lipoproteins on inducible mouse macrophage gene expression are gene and stimulus dependent. J Clin Invest. 1995;95:2020–7. doi: 10.1172/JCI117887. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47.Mulugeta S, Beers MF. Surfactant protein C: its unique properties and emerging immunomodulatory role in the lung. Microbes Infect. 2006;8:2317–23. doi: 10.1016/j.micinf.2006.04.009. [DOI] [PubMed] [Google Scholar]
- 48.Chaby R, et al. Interactions between LPS and lung surfactant proteins. J Endotoxin Res. 2005;11:181–5. doi: 10.1179/096805105X37358. [DOI] [PubMed] [Google Scholar]
- 49.Muhvic D, et al. The involvement of CD14 in the activation of human monocytes by peptidoglycan monomers. Mediators Inflamm. 2001;10:155–62. doi: 10.1080/09629350123956. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50.Min KS, et al. Induction of hepatic metallothionein by nonmetallic compounds associated with acute-phase response in inflammation. Toxicol Appl Pharmacol. 1991;111:152–62. doi: 10.1016/0041-008x(91)90144-4. [DOI] [PubMed] [Google Scholar]
- 51.Penkowa M, et al. Metallothionein reduces central nervous system inflammation, neurodegeneration, and cell death following kainic acid-induced epileptic seizures. J Neurosci Res. 2005;79:522–34. doi: 10.1002/jnr.20387. [DOI] [PubMed] [Google Scholar]
- 52.Coyle P, et al. Metallothionein: the multipurpose protein. Cell Mol Life Sci. 2002;59:627–47. doi: 10.1007/s00018-002-8454-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 53.Piedboeuf B, et al. Increased expression of tissue inhibitor of metalloproteinases (TIMP-I) and metallothionein in murine lungs after hyperoxic exposure. Am J Respir Cell Mol Biol. 1994;10:123–32. doi: 10.1165/ajrcmb.10.2.8110467. [DOI] [PubMed] [Google Scholar]
- 54.Kaetzel CS. The polymeric immunoglobulin receptor: bridging innate and adaptive immune responses at mucosal surfaces. Immunol Rev. 2005;206:83–99. doi: 10.1111/j.0105-2896.2005.00278.x. [DOI] [PubMed] [Google Scholar]
- 55.Vasconcelos D, et al. Pathology of inhalation anthrax in cynomolgus monkeys (Macaca fascicularis) Lab Invest. 2003;83:1201–9. doi: 10.1097/01.lab.0000080599.43791.01. [DOI] [PubMed] [Google Scholar]
- 56.Seltman M, et al. Assessment of a systematic expression profiling approach in ENU-induced mouse mutant lines. Mammalian Genome. 2005;16:1–10. doi: 10.1007/s00335-004-3012-x. [DOI] [PubMed] [Google Scholar]
- 57.Acín S, et al. Microarray analysis of hepatic genes differentially expressed in the presence of the unsaponifiable fraction of olive oil in apolipoprotein E-deficient mice. British Journal of Nutrition. 2007;97:628–38. doi: 10.1017/S0007114507657912. [DOI] [PubMed] [Google Scholar]
- 58.Shen G, et al. Comparison of (−)-Epigallocatechin-3-Gallate Elicited Liver and Small Intestine Gene Expression Profiles Between C57BL/6J Mice and C57BL/6J/Nrf2 (−/−) Mice. Pharm Res. 2005;22:1805–20. doi: 10.1007/s11095-005-7546-8. [DOI] [PubMed] [Google Scholar]
- 59.Suzuki Y, Nakayama M. Differential Profiles of Genes Expressed in Neonatal Brain of 129X1/SvJ and C57BL/6J Mice: A Database to Aid in Analyzing DNA Microarrays using Nonisogenic Gene-targeted Mice. DNA Res. 2003;10:293–275. doi: 10.1093/dnares/10.6.263. [DOI] [PubMed] [Google Scholar]
- 60.Waelput W, et al. Identification and expression analysis of leptin-regulated immediate early response and late target genes. Biochem J. 2000;348:55–61. [PMC free article] [PubMed] [Google Scholar]
- 61.Folch-Puy E, et al. Pancreatitis-associated protein I suppresses NF-kappa B activation through a JAK/STAT-mediated mechanism in epithelial cells. J Immunol. 2006;176:3774–9. doi: 10.4049/jimmunol.176.6.3774. [DOI] [PubMed] [Google Scholar]
- 62.Garcia VE, et al. Single-cell cytokine analysis of gamma delta T cell responses to nonpeptide mycobacterial antigens. J Immunol. 1997;159:1328–35. [PubMed] [Google Scholar]
- 63.van der Merwe PA, et al. Affinity and kinetic analysis of the interaction of the cell adhesion molecules rat CD2 and CD48. Embo J. 1993;12:4945–54. doi: 10.1002/j.1460-2075.1993.tb06188.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 64.Malaviya R, et al. The mast cell tumor necrosis factor alpha response to FimH-expressing Escherichia coli is mediated by the glycosylphosphatidylinositol-anchored molecule CD48. Proc Natl Acad Sci U S A. 1999;96:8110–5. doi: 10.1073/pnas.96.14.8110. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 65.Abadia-Molina AC, et al. CD48 controls T-cell and antigen-presenting cell functions in experimental colitis. Gastroenterology. 2006;130:424–34. doi: 10.1053/j.gastro.2005.12.009. [DOI] [PubMed] [Google Scholar]
- 66.Assarsson E, et al. NK cells stimulate proliferation of T and NK cells through 2B4/CD48 interactions. J Immunol. 2004;173:174–80. doi: 10.4049/jimmunol.173.1.174. [DOI] [PubMed] [Google Scholar]
- 67.Gonzalez-Cabrero J, et al. CD48-deficient mice have a pronounced defect in CD4(+) T cell activation. Proc Natl Acad Sci U S A. 1999;96:1019–23. doi: 10.1073/pnas.96.3.1019. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 68.Cotlin LF, et al. Casein kinase II activity is required for transferrin receptor endocytosis. J Biol Chem. 1999;274:30550–6. doi: 10.1074/jbc.274.43.30550. [DOI] [PubMed] [Google Scholar]
- 69.Wang S, Jones KA. CK2 controls the recruitment of Wnt regulators to target genes in vivo. Curr Biol. 2006;16:2239–44. doi: 10.1016/j.cub.2006.09.034. [DOI] [PubMed] [Google Scholar]
- 70.Gao Y, Wang HY. Casein kinase 2 is activated and essential for Wnt/beta-catenin signaling. J Biol Chem. 2006;281:18394–400. doi: 10.1074/jbc.M601112200. [DOI] [PubMed] [Google Scholar]
- 71.Li PF, et al. Phosphorylation by protein kinase CK2: a signaling switch for the caspase-inhibiting protein ARC. Mol Cell. 2002;10:247–58. doi: 10.1016/s1097-2765(02)00600-7. [DOI] [PubMed] [Google Scholar]
- 72.Baynes R, et al. Transferrin receptors and transferrin iron uptake by cultured human blood monocytes. Eur J Cell Biol. 1987;43:372–6. [PubMed] [Google Scholar]
- 73.Lee JY, et al. Biosynthetic analysis of the petrobactin siderophore pathway from Bacillus anthracis. J Bacteriol. 2007;189:1698–710. doi: 10.1128/JB.01526-06. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 74.Cendrowski S, et al. Bacillus anthracis requires siderophore biosynthesis for growth in macrophages and mouse virulence. Mol Microbiol. 2004;51:407–17. doi: 10.1046/j.1365-2958.2003.03861.x. [DOI] [PubMed] [Google Scholar]
- 75.Olferiev M, et al. The role of activating protein 1 in the transcriptional regulation of the human FCGR2B promoter mediated by the −343 G -> C polymorphism associated with systemic lupus erythematosus. J Biol Chem. 2007;282:1738–46. doi: 10.1074/jbc.M605808200. [DOI] [PubMed] [Google Scholar]
- 76.Rangel R, et al. Generation of memory CD4+, CD8+, CD45RO+ and CD16- lymphocytes activated with IL-2, INF-gamma, and TNF-alpha with specific cytotoxicity against autologous cervical cancer cells in a mixed leukocyte-tumour cell culture. Eur Cytokine Netw. 1995;6:195–202. [PubMed] [Google Scholar]
- 77.Bachmann MF, et al. Functional properties and lineage relationship of CD8+ T cell subsets identified by expression of IL-7 receptor alpha and CD62L. J Immunol. 2005;175:4686–96. doi: 10.4049/jimmunol.175.7.4686. [DOI] [PubMed] [Google Scholar]
- 78.Kim SV, Flavell RA. Immunology. CD8alphaalpha and T cell memory. Science. 2004;304:529–30. doi: 10.1126/science.1097678. [DOI] [PubMed] [Google Scholar]
- 79.Madakamutil LT, et al. CD8alphaalpha-mediated survival and differentiation of CD8 memory T cell precursors. Science. 2004;304:590–3. doi: 10.1126/science.1092316. [DOI] [PubMed] [Google Scholar]
- 80.Sorensen O, et al. An ELISA for hCAP-18, the cathelicidin present in human neutrophils and plasma. J Immunol Methods. 1997;206:53–9. doi: 10.1016/s0022-1759(97)00084-7. [DOI] [PubMed] [Google Scholar]
- 81.Buttner C, et al. Transcriptional activation of the type I collagen genes COL1A1 and COL1A2 in fibroblasts by interleukin-4: analysis of the functional collagen promoter sequences. J Cell Physiol. 2004;198:248–58. doi: 10.1002/jcp.10395. [DOI] [PubMed] [Google Scholar]
- 82.Truter S, et al. Pro-alpha 2(V) collagen gene; pairwise analysis of the amino-propeptide coding domain, and cross-species comparison of the promoter sequence. Connect Tissue Res. 1993;29:51–9. doi: 10.3109/03008209309061966. [DOI] [PubMed] [Google Scholar]
- 83.Warburton MJ, et al. Distribution and synthesis of type V collagen in the rat mammary gland. J Histochem Cytochem. 1983;31:1265–73. doi: 10.1177/31.11.6352797. [DOI] [PubMed] [Google Scholar]
- 84.Linsenmayer TF, et al. Extracellular matrices in the developing avian eye: type V collagen in corneal and noncorneal tissues. Invest Ophthalmol Vis Sci. 1984;25:41–7. [PubMed] [Google Scholar]
- 85.Schuppan D, et al. Immunofluorescent localization of type-V collagen as a fibrillar component of the interstitial connective tissue of human oral mucosa, artery and liver. Cell Tissue Res. 1986;243:535–43. doi: 10.1007/BF00218060. [DOI] [PubMed] [Google Scholar]
- 86.Pokutta S, Weis WI. Structure and Mechanism of Cadherins and Catenins in Cell-Cell Contacts. Annu Rev Cell Dev Biol. 2007:23. doi: 10.1146/annurev.cellbio.22.010305.104241. [DOI] [PubMed] [Google Scholar]
- 87.Charrasse S, et al. Variation in cadherins and catenins expression is linked to both proliferation and transformation of Rhabdomyosarcoma. Oncogene. 2004;23:2420–30. doi: 10.1038/sj.onc.1207382. [DOI] [PubMed] [Google Scholar]
- 88.Protasiewicz J, Adamiec R. The role of CD44 in pathogenesis of atherosclerosis. Pol Merkur Lekarski. 2005;19:559–62. [PubMed] [Google Scholar]
- 89.Deem TL, Cook-Mills JM. Vascular cell adhesion molecule 1 (VCAM-1) activation of endothelial cell matrix metalloproteinases: role of reactive oxygen species. Blood. 2004;104:2385–93. doi: 10.1182/blood-2004-02-0665. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 90.Shimosawa T, et al. Adrenomedullin, an endogenous peptide, counteracts cardiovascular damage. Circulation. 2002;105:106–11. doi: 10.1161/hc0102.101399. [DOI] [PubMed] [Google Scholar]
- 91.Shimosawa T, et al. Organ-protective effects of adrenomedullin. Hypertens Res. 2003;26:S109–12. doi: 10.1291/hypres.26.s109. [DOI] [PubMed] [Google Scholar]
- 92.Awan MM, Saggerson ED. Malonyl-CoA metabolism in cardiac myocytes and its relevance to the control of fatty acid oxidation. Biochem J. 1993;295:61–6. doi: 10.1042/bj2950061. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 93.van der Vusse GJ, et al. Fatty acid homeostasis in the normoxic and ischemic heart. Physiol Rev. 1992;72:881–940. doi: 10.1152/physrev.1992.72.4.881. [DOI] [PubMed] [Google Scholar]
- 94.Neely JR, et al. Myocardial utilization of carbohydrate and lipids. Prog Cardiovasc Dis. 1972;15:289–329. doi: 10.1016/0033-0620(72)90029-1. [DOI] [PubMed] [Google Scholar]
- 95.Firoved AM, et al. Bacillus anthracis edema toxin causes extensive tissue lesions and rapid lethality in mice. Am J Pathol. 2005;167:1309–20. doi: 10.1016/S0002-9440(10)61218-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 96.Glomski IJ, et al. Murine splenocytes produce inflammatory cytokines in a MyD88-dependent response to Bacillus anthracis spores. Cell Microbiol. 2007;9:502–13. doi: 10.1111/j.1462-5822.2006.00806.x. [DOI] [PubMed] [Google Scholar]
- 97.Hoover DL, et al. Anthrax edema toxin differentially regulates lipopolysaccharide-induced monocyte production of tumor necrosis factor alpha and interleukin-6 by increasing intracellular cyclic AMP. Infect Immun. 1994;62:4432–9. doi: 10.1128/iai.62.10.4432-4439.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 98.Erwin JL, et al. Macrophage-derived cell lines do not express proinflammatory cytokines after exposure to Bacillus anthracis lethal toxin. Infect Immun. 2001;69:1175–7. doi: 10.1128/IAI.69.2.1175-1177.2001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 99.Park JM, et al. Anthrolysin O and other gram-positive cytolysins are toll-like receptor 4 agonists. J Exp Med. 2004;200:1647–55. doi: 10.1084/jem.20041215. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 100.Remer KA, et al. Evidence for involvement of peptidoglycan in the triggering of an oxidative burst by Listeria monocytogenes in phagocytes. Clin Exp Immunol. 2005;140:73–80. doi: 10.1111/j.1365-2249.2005.02740.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 101.Abboud G, Kaplowitz N. Drug-induced liver injury. Drug Saf. 2007;30:277–94. doi: 10.2165/00002018-200730040-00001. [DOI] [PubMed] [Google Scholar]
- 102.Muftuoglu MA, et al. Liver injury in sepsis and abdominal compartment syndrome in rats. Surg Today. 2006;36:519–24. doi: 10.1007/s00595-006-3196-7. [DOI] [PubMed] [Google Scholar]
- 103.Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(−Delta Delta C(T)) Method. Methods. 2001;25:402–8. doi: 10.1006/meth.2001.1262. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.



